Company
23andMe
23andMe offers DNA testing kits that provide ancestry information, family connections, and genetic health insights. The company serves consumers interested in learning their geographic origins, building family trees, and understanding genetic predispositions to health conditions. Service tiers range from basic ancestry reports to comprehensive plans including health screenings, carrier reports, and exome sequencing.
23andMe is a publicly traded company operating in the healthcare sector, based in USA.
Leadership
Former
_(cropped).jpg?width=400){kind=small}
Recent developments
AI summary of recent coverageRecent coverage has focused on 23andMe's financial difficulties and settlement obligations following a significant data breach. The company has faced multiple settlements totaling tens of millions of dollars to compensate affected customers and state authorities, with courts approving payouts of approximately $46-47 million to data breach victims. Coverage has also documented the company's dramatic decline from its former valuation to bankruptcy proceedings and a subsequent nonprofit acquisition.
Summarized from the headlines in the sidebar; see each source for the full story.